Zhejiang Garden Bio-Chemical reports strong growth, proposes dividend

Zhejiang Garden Bio-Chemical High-tech (SZSE:300401) announced a robust financial performance for 2024, underpinned by its strategic focus on vitamins and pharmaceuticals. Revenue reached ¥1,243.28 million, a 13.58% increase year-over-year, while net profit attributable to shareholders soared by 60.76% to ¥309.21 million. The company's robust financials prompt a proposed cash dividend of ¥1.14 per 10 shares, totaling ¥61.96 million and representing 52.38% of the net profits attributable to shareholders, alongside plans for share repurchase, pending shareholder approval.